当前位置: 首页 >> 检索结果
142. Individualized Prediction of Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia.
作者: Hilde van der Staaij.;Ilaria Prosepe.;Camila Caram-Deelder.;Ruth H Keogh.;Emöke Deschmann.;Christof Dame.;Wes Onland.;Sandra A Prins.;Florian Cassel.;Esther J d'Haens.;Elke van Westering-Kroon.;Peter Andriessen.;Sabine L Vrancken.;Christian V Hulzebos.;Daniel C Vijlbrief.;Suzanne F Fustolo-Gunnink.;Karin Fijnvandraat.;Enrico Lopriore.;Johanna G van der Bom.;Nan van Geloven.
来源: JAMA. 2025年334卷14期1267-1277页
Preterm infants with severe thrombocytopenia (platelet count <50 × 109/L) frequently receive platelet transfusions. However, it is unclear in what cases prophylactic transfusion truly reduces bleeding risk or whether it does more harm than good.
143. Superficial Vein Thrombosis: A Review.
作者: Gregory Piazza.;Darsiya Krishnathasan.;Nada Hamade.;Francisco Ujueta.;Giovanni Scimeca.;Marcos D Ortiz-Rios.;Bridget McGonagle.;Jean-Philippe Galanaud.;David Jiménez.;Manuel Monreal.;John Fanikos.;Anahita Dua.;Leben Tefera.;Raghu Kolluri.;Sahil A Parikh.;Walter Ageno.;Samuel Z Goldhaber.;Jeffrey I Weitz.;Lisa K Moores.;Isabelle Quéré.;Behnood Bikdeli.
来源: JAMA. 2025年
Superficial vein thrombosis (SuVT) is characterized by thrombus in the superficial veins, typically in the lower or upper extremities, and has an estimated annual incidence of 64 to 131 per 100 000 person-years. Approximately 10% of patients with SuVT progress to deep vein thrombosis (DVT) or pulmonary embolism (PE).
159. Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
作者: Alexander B C D Ng.;Aqua Asif.;Ridhi Agarwal.;Valeria Panebianco.;Rossano Girometti.;Sangeet Ghai.;Enrique Gómez-Gómez.;Lars Budäus.;Tristan Barrett.;Jan Philipp Radtke.;Claudia Kesch.;Francesco De Cobelli.;Tho Pham.;Samir S Taneja.;Jim C Hu.;Ash Tewari.;Miguel Á Rodríguez Cabello.;Adriano B Dias.;Lance A Mynderse.;Marcelo Borghi.;Lars Boesen.;Paras Singh.;Raphaële Renard-Penna.;Jeffrey J Leow.;Fabian Falkenbach.;Martina Pecoraro.;Gianluca Giannarini.;Nathan Perlis.;Daniel López-Ruiz.;Christof Kastner.;Lars Schimmöller.;Marimo Rossiter.;Arjun Nathan.;Pramit Khetrapal.;Vinson Wai-Shun Chan.;Aiman Haider.;Caroline S Clarke.;Shonit Punwani.;Chris Brew-Graves.;Louise Dickinson.;Anita Mitra.;Giorgio Brembilla.;Daniel J A Margolis.;Yemisi Takwoingi.;Mark Emberton.;Clare Allen.;Francesco Giganti.;Caroline M Moore.;Veeru Kasivisvanathan.; .
来源: JAMA. 2025年334卷13期1170-1179页
Multiparametric magnetic resonance imaging (MRI), with or without prostate biopsy, has become the standard of care for diagnosing clinically significant prostate cancer. Resource capacity limits widespread adoption. Biparametric MRI, which omits the gadolinium contrast sequence, is a shorter and cheaper alternative offering time-saving capacity gains for health systems globally.
|